- ARK Genomic (ARKG)*
- Brazil small Cap ETF (EWZS)
Trading an ETF, we are more focused on the technical readings and the industry performance as it relates to the flow of funds more so than having concerns about company risk. As an industry, the fall has been from February 2021 to May 2022. Enough time to go from very over bought to very over-sold. The RSI has crossed above its 505 line. This indicates that ARKG is now performing better than 53% of the market. This is a plus. It shows money is being attracted to the industry. Price crossing the 50 Continue reading